Two instillations of epirubicin as prophylaxis for recurrence after transurethral resection of Ta and T1 transitional cell bladder cancer: a prospective, randomized controlled study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples